HCA Healthcare Inc (NYSE: HCA) shares are trading lower after the company reported mixed Q3 FY23 financial results and updated guidance.

The company reported revenue of $16.213 billion, exceeding the consensus of $15.822 billion.

Same facility admissions rose 3.4 Y/Y, and same facility equivalent admissions grew 4.1% Y/Y. 

Same facility emergency room visits were up 3.5% Y/Y, and same facility revenue per equivalent admission rose 3.6% Y/Y.

Adjusted EBITDA declined to $2.880 billion from $2.902 billion a year ago.

EPS of $3.91 

Full story available on Benzinga.com